Semaphorin-7a reverses the ERF-induced inhibition of EMT in Ras-dependent mouse mammary epithelial cells

Molecular Biology of the Cell

Volumn 23, Issue 19, 2012, Pages 3873-3881

  Allegra, Maryline ^a,b,d   Zaragkoulias, Andreas ^a,b   Vorgia, Elena ^a,b   Ioannou, Marina ^b   Litos, Gabriele ^c   Beug, Hartmut ^c   Mavrothalassitis, George ^a,b  

^a UNIVERSITY OF CRETE   (Greece)

^b INSTITUTE OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY   (Greece)

^c RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^d CENTRE MÉDITERRANÉEN DE MÉDECINE MOLÉCULAIRE C3M   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN SEMAPHORIN 7A; SEMAPHORIN; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST EPITHELIUM; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; MOUSE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AMINO ACID SUBSTITUTION; ANIMALS; ANTIGENS, CD; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; MAMMARY GLANDS, ANIMAL; MAP KINASE SIGNALING SYSTEM; MICE; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RAS PROTEINS; REPRESSOR PROTEINS; SEMAPHORINS; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA;

EID: 84867144414     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E12-04-0276     Document Type: Article

References (56)

1. Aitola M, Carlsson P, Mahlapuu M, Enerback S, Pelto-Huikko M (2000). Forkhead transcription factor FoxF2 is expressed in mesodermal tissues involved in epithelio-mesenchymal interactions. Dev Dyn 218, 136-149. (Pubitemid 30249757)
2. Athanasiou M, LeGallic L, Watson DK, Blair DG, Mavrothalassitis G (2000). Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids. Cancer Gene Ther 7, 1188-1195. (Pubitemid 30661037)
3. Bielenberg DR, Klagsbrun M (2007). Targeting endothelial and tumor cells with semaphorins. Cancer Metastasis Rev 26, 421-431. (Pubitemid 350115126)
4. Bolos V, Peinado H, Perez-Moreno MA, Fraga MF, Esteller M, Cano A (2003). The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci 116, 499-511. (Pubitemid 36231290)
5. Boyer B, Vallâes AM, Edme N (2000). Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol 60, 1091-1099.
6. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA (2000). The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2, 76-83.
7. Christofori G, Semb H (1999). The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 24, 73-76. (Pubitemid 29346577)
8. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D, van Roy F (2001). The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 7, 1267-1278. (Pubitemid 32607360)
9. Czopik AK, Bynoe MS, Palm N, Raine CS, Medzhitov R (2006). Semaphorin 7A is a negative regulator of T cell responses. Immunity 24, 591-600. (Pubitemid 43728148)
10. Delannoy-Courdent A, Mattot V, Fafeur V, Fauquette W, Pollet I, Calmels T, Vercamer C, Boilly B, Vandenbunder B, Desbiens X (1998). The expression of an Ets1 transcription factor lacking its activation domain decreases uPA proteolytic activity and cell motility, and impairs normal tubulogenesis and cancerous scattering in mammary epithelial cells. J Cell Sci 111, 1521-1534. (Pubitemid 28288824)
11. Dong C, Zhu S, Wang T, Yoon W, Goldschmidt-Clermont PJ (2002). Upregulation of PAI-1 is mediated through TGF-β/Smad pathway in transplant arteriopathy. J Heart Lung Transplant 21, 999-1008. (Pubitemid 35291149)
12. Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber M, Berx G, Cano A, Beug H, Foisner R (2005). DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 24, 2375-2385. (Pubitemid 40546696)
13. Eger A, Stockinger A, Park J, Langkopf E, Mikula M, Gotzmann J, Mikulits W, Beug H, Foisner R (2004). beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition. Oncogene 23, 2672-2680. (Pubitemid 38586321)
14. Fialka I, Schwarz H, Reichmann E, Oft M, Busslinger M, Beug H (1996). The estrogen-dependent c-JunER protein causes a reversible loss of mammary epithelial cell polarity involving a destabilization of adherens junctions. J Cell Biol 132, 1115-1132.
15. Gan Y et al. (2011). Role of semaphorin 7a signaling in transforming growth factor beta1-induced lung fibrosis and scleroderma-related interstitial lung disease. Arthritis Rheum 63, 2484-2494.
16. Grunert S, Jechlinger M, Beug H (2003). Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol 4, 657-665. (Pubitemid 36934968)
17. Huber MA, Azoitei N, Baumann B, Grunert S, Sommer A, Pehamberger H, Kraut N, Beug H, Wirth T (2004). NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 114, 569-581.
18. Huber MA, Kraut N, Beug H (2005). Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17, 548-558.
19. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, Thompson EW (2007). Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 213, 374-383. (Pubitemid 47509716)
20. Janda E, Lehmann K, Killisch I, Jechlinger M, Herzig M, Downward J, Beug H, Grèunert S (2002a). Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol 156, 299-313. (Pubitemid 34839911)
21. Janda E, Litos G, Grunert S, Downward J, Beug H (2002b). Oncogenic Ras/Her-2 mediate hyperproliferation of polarized epithelial cells in 3D cultures and rapid tumor growth via the PI3K pathway. Oncogene 21, 5148-5159.
22. Jechlinger M, Grunert S, Tamir IH, Janda E, Ludemann S, Waerner T, Seither P, Weith A, Beug H, Kraut N (2003). Expression profiling of epithelial plasticity in tumor progression. Oncogene 22, 7155-7169. (Pubitemid 37378548)
23. Kang HR, Lee CG, Homer RJ, Elias JA (2007). Semaphorin 7A plays a critical role in TGF-β1-induced pulmonary fibrosis. J Exp Med 204, 1083-1093. (Pubitemid 46798152)
24. Kim K, Lu Z, Hay ED (2002). Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol Int 26, 463-476. (Pubitemid 34762099)
25. Kowanetz M, Valcourt U, Bergstrom R, Heldin CH, Moustakas A (2004). Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein. Mol Cell Biol 24, 4241-4254. (Pubitemid 41070996)
26. Kruger RP, Aurandt J, Guan KL (2005). Semaphorins command cells to move. Nat Rev Mol Cell Biol 6, 789-800. (Pubitemid 41726117)
27. Lahsnig C, Mikula C, Petz M, Zulehner M, Schneller G, van Zijl DF, Huber H, Csiszar A, Beug H, Mikulits W (2008). ILEI requires oncogenic for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progression. Oncogene 28, 638-650.
28. Lange C, Liehr T, Goen M, Gebhart E, Fleckenstein B, Ensser A (1998). New eukaryotic semaphorins with close homology to semaphorins of DNA viruses. Genomics 51, 340-350. (Pubitemid 28413200)
29. Lazova R, Gould Rothberg BE, Rimm D, Scott G (2009). The Semaphorin 7A receptor Plexin C1 is lost during melanoma metastasis. Am J Dermatopathol 31, 177-181.
30. Le Gallic L, Sgouras D, Beal G Jr, Mavrothalassitis G (1999). Transcriptional repressor ERF is a Ras/mitogen-activated protein kinase target that regulates cellular proliferation. Mol Cell Biol 19, 4121-4133. (Pubitemid 29241986)
31. Le Gallic L, Virgilio L, Cohen P, Biteau B, Mavrothalassitis G (2004). ERF nuclear shuttling, a continuous monitor of Erk activity that links it to cell cycle progression. Mol Cell Biol 24, 1206-1218. (Pubitemid 38112183)
32. Messina A et al. (2011). Dysregulation of Semaphorin7A/β1-integrin signaling leads to defective GnRH-1 cell migration, abnormal gonadal development and altered fertility. Hum Mol Genet 20, 4759-4774.
33. Montesano R, Soriano JV, Fialka I, Orci L (1998). Isolation of EpH4 mammary epithelial cell subpopulations which differ in their morphogenetic properties. In Vitro Cell Dev Biol Anim 34, 468-477. (Pubitemid 29071771)
34. Moreno-Bueno G et al. (2006). Genetic profiling of epithelial cells expressing e-cadherin repressors reveals a distinct role for snail, slug, and e47 factors in epithelial-mesenchymal transition. Cancer Res 66, 9543-9556. (Pubitemid 44623653)
35. Moustakas A, Heldin CH (2007). Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98, 1512-1520. (Pubitemid 47308444)
36. Neufeld G, Shraga-Heled N, Lange T, Guttmann-Raviv N, Herzog Y, Kessler O (2005). Semaphorins in cancer. Front Biosci 10, 751-760.
37. Oft M, Heider KH, Beug H (1998). TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 8, 1243-1252. (Pubitemid 28540052)
38. Oft M, Peli J, Rudaz C, Schwarz H, Beug H, Reichmann E (1996). TGF-β1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 10, 2462-2477. (Pubitemid 26341881)
39. Ojakian GK, Nelson WJ, Beck KA (1997). Mechanisms for de novo biogenesis of an apical membrane compartment in groups of simple epithelial cells surrounded by extracellular matrix. J Cell Sci 110, 2781-2794. (Pubitemid 27514108)
40. Papadaki C, Alexiou M, Cecena G, Verykokakis M, Bilitou A, Cross JC, Oshima RG, Mavrothalassitis G (2007). Transcriptional repressor erf determines extraembryonic ectoderm differentiation. Mol Cell Biol 27, 5201-5213. (Pubitemid 47068293)
41. Pasterkamp RJ, Kolk SM, Hellemons AJ, Kolodkin AL (2007). Expression patterns of semaphorin7A and plexinC1 during rat neural development suggest roles in axon guidance and neuronal migration. BMC Dev Biol 7, 98.
42. Polychronopoulos S, Verykokakis M, Yazicioglu MN, Sakarellos-Daitsiotis M, Cobb MH, Mavrothalassitis G (2006). The transcriptional ETS2 repressor factor associates with active and inactive Erks through distinct FXF motifs. J Biol Chem 281, 25601-25611. (Pubitemid 44401949)
43. Scott GA, McClelland LA, Fricke AF, Fender A (2009). Plexin C1, a receptor for semaphorin 7a, inactivates cofilin and is a potential tumor suppressor for melanoma progression. J Invest Dermatol 129, 954-963.
44. Sgouras DN, Athanasiou MA, Beal GJ Jr, Fisher RJ, Blair DG, Mavrothalassitis GJ (1995). ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation. EMBO J 14, 4781-4793.
45. Shook D, Keller R (2003). Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development. Mech Dev 120, 1351-1383. (Pubitemid 37421168)
46. Sun D, Baur S, Hay ED (2000). Epithelial-mesenchymal transformation is the mechanism for fusion of the craniofacial primordia involved in morphogenesis of the chicken lip. Dev Biol 228, 337-349. (Pubitemid 32011996)
47. Suzuki K, Kumanogoh A, Kikutani H (2008). Semaphorins and their receptors in immune cell interactions. Nat Immunol 9, 17-23. (Pubitemid 350286199)
48. Tarcic G et al. (2012). EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF. FASEB J 26, 1582-1592.
49. Thiery JP (2003). Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15, 740-746.
50. Trimboli AJ et al. (2008). Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res 68, 937-945.
51. Vernon AE, LaBonne C (2004). Tumor metastasis: a new twist on epithelial-mesenchymal transitions. Curr Biol 14, R719-R721. (Pubitemid 39290047)
52. Verykokakis M, Papadaki C, Vorgia E, Le Gallic L, Mavrothalassitis G (2007). The Ras-dependent Erf control of cell proliferation and differentiation is mediated by c-Myc repression. J Biol Chem 282, 30285-30294. (Pubitemid 350041549)
53. Waerner T, Alacakaptan M, Tamir I, Oberauer R, Gal A, Brabletz T, Schreiber M, Jechlinger M, Beug H (2006). ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells. Cancer Cell 10, 227-239. (Pubitemid 44311068)
54. Walker MM, Ellis SM, Auza MJ, Patel A, Clark P (2008). The intercellular adhesion molecule, cadherin-10, is a marker for human prostate luminal epithelial cells that is not expressed in prostate cancer. Mod Pathol 21, 85-95. (Pubitemid 351172163)
55. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA (2004). Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927-939. (Pubitemid 38798858)
56. Zhou Y, Gunput RA, Pasterkamp RJ (2008). Semaphorin signaling: progress made and promises ahead. Trends Biochem Sci 33, 161-170.